semaglutide and humira Focus: AbbVie's gets a U.S. rival, but costs could stay high A recent Veterans Health Administration–based

ASCO GI 2026 data suggest GLP-1 agents may complement aspirin in colorectal cancer prevention by targeting metabolic risk, though evidence remains observational.

Nooms new Microdose GLP-1Rx Program could be a game changer by leveraging low-dose compounded semaglutide with clinical coaching to reduce side effects and cut costs

There is direct evidence comparing semaglutide to sitagliptin and dulaglutide in patients inadequately controlled on one oral antidiabetic drug (OAD), and to exenatide or insulin glargine in patients with inadequate glycemic control with one or two OADs, however data are lacking for other comparators

Produces 610 lb fruits that fit easily in the fridge or icebox

GLP-3 30mg pen with 300 x 100mcg units